Greenwich LifeSciences, Inc.
For the period ended Dec 31, 2024. Filed Apr 15, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Apr 15, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Power of Attorney (included on signature page hereto)
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and appoints Snehal Patel as his or her attorney-in-fact, with full power of substitution and resubstitution, for him or her in any and all capacities, to sign any and all amendments to this Annual Report on Form 10-K, and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney-in-fact full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorney-in-fact, or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Exchange Act of 1934, this Report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.
| SIGNATURE | TITLE | DATE |
|---|---|---|
| /s/ Snehal Patel | Chief Executive Officer and Director | April 15, 2025 |
| Snehal Patel | (Principal Executive Officer and Principal Accounting and Financial Officer) | |
| /s/ F. Joseph Daugherty | Chief Medical Officer and Director | April 15, 2025 |
| F. Joseph Daugherty | ||
| /s/ David McWilliams | Director | April 15, 2025 |
| David McWilliams | ||
| /s/ Eric Rothe | Director | April 15, 2025 |
| Eric Rothe | ||
| /s/ Kenneth Hallock | Director | April 15, 2025 |
| Kenneth Hallock | ||
Index to Financial Statements
| Report of Independent Registered Public Accounting Firm | F-2 |
|---|---|
| Balance Sheets | F-4 |
| Statements of Operations | F-5 |
| Statements of Stockholders’ Equity | F-6 |
| Statements of Cash Flows | F-7 |
| Notes to Financial Statements | F-8 |
Texas Office: 7915 FM 1960 West Suite 220 Houston, TX 77070 www.rbsmllp.com
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.